A Phase 2 Randomized Trial of Caloric Restriction and Activity to Reduce Chemoresistance in B-Cell Acute Lymphoblastic Leukemia (IDEAL2)

Is this Study for You?

Let's Get Started!

Details
Age

Child to Adult

Type of Study

Treatment

Locations

Childrens Hospital Colorado

Principal Investigator
Photograph of Lisa Hartman,  MD

Lisa Hartman, MD

Study ID

Protocol Number: 22-0837

More information available at ClinicalTrials.gov: NCT05082519

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers